The impact of episodic screening interruption: COVID-19 and population-based cancer screening in Canada.
Jean He YongJames G MainprizeMartin Joel YaffeYibing RuanAbbey E PoirierAndrew ColdmanClaude NadeauNicolas IragorriRobert J HilsdenDarren R BrennerPublished in: Journal of medical screening (2020)
Interruptions in cancer screening will lead to additional cancer deaths, additional advanced cancers diagnosed, and a surge in demand for downstream resources when screening resumes. An effective strategy is needed to minimize potential harm to people who missed their screening.